Cadila receives US FDA approval for carvedilol tab (PharmaBiz)
Cadila Healthcare Ltd has received an approval from the US FDA to market carvedilol tablets 3.125 mg, 6.25 mg, 12.5 mg. and 25 mg., in the US market. The drug falls in the cardiovascular segment.

Poniard Pharmaceuticals Receives FDA Fast Track Designation For Picoplatin For Treatment Of Small Cell Lung Cancer (Medical News Today)
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, announced that it has been granted fast track designation by the U.S. Food and Drug Administration (FDA) for its lead product candidate, picoplatin, for the second-line treatment of refractory or resistant small cell lung cancer (SCLC). [click link for full article]